PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
PULSE BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$47.55+3.12 (+7.02%)
Close on Oct 19, 2026
- Market cap
- $3.29B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$29.99 (+170.8%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
PULSE BIOSCIENCES, INC. reported revenue of $1.19M for the twelve months to Jun 30, 2026. Free cash flow was -$61.39M.
Revenue
$1.19M
TTM Q2 2026
Operating income
-$83.04M
TTM Q2 2026
Free cash flow
-$61.39M
TTM Q2 2026
EPS, diluted
-$1.18
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $3.29B
- P/E ratio
- –
- Price to sales
- 2776.76
- Price to book
- 33.07
- Dividend yield
- –
- Free cash flow yield
- -1.87%
Fundamentals
- Revenue
- $1.19M
- Net income
- -$80.06M
- EPS, diluted
- -$1.18
- Free cash flow
- -$61.39M
- Book value per share
- $1.44
- Diluted shares
- 69M
Twelve years at a glance
Fiscal years 2014 to 2025 and trailing twelve months, USD
Revenue
$1.19M
Gross profit
$3.00K
Operating income
-$83.04M
Net income
-$80.06M
EPS, diluted
-$1.18
Free cash flow
-$61.39M
Reported periodTrailing twelve months